Northway Biotechpharma is partnering with Switzerland's biotech company Memo Therapeutics (MTx) for the fast-track manufacturing of a SARS-CoV-2-neutralizing antibody for treating the coronavirus, the Vilnius-based biopharmaceutical product contract development and manufacturing company said on Frid...
